NCKAP1 improves patient outcome and inhibits cell growth by enhancing Rb1/p53 activation in hepatocellular carcinoma

In our previous report, we identified miR-34c-3p as an independent factor contributing to the carcinogenesis of hepatocellular carcinoma (HCC) by targeting NCK Associated Protein 1 (NCKAP1). NCKAP1 has been known to promote the malignancy of cancer cells by disrupting the structural stability of WAS...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Xiao-ping, Kan, Anna, Ling, Yi-hong, Lu, Liang-he, Mei, Jie, Wei, Wei, Li, Shao-hua, Guo, Rong-ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506474/
https://www.ncbi.nlm.nih.gov/pubmed/31068575
http://dx.doi.org/10.1038/s41419-019-1603-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506474/
https://www.ncbi.nlm.nih.gov/pubmed/31068575
http://dx.doi.org/10.1038/s41419-019-1603-4

Ejemplares similares